Regulation of Gluconeogenesis and Glycogen Metabolism

Demonstrate the route before regulating it.

Two Routes That Lose Capacity in Culture

RoutePhysiological roleBehaviour in culture
GluconeogenesisGlucose synthesis from lactate, glycerol, amino acidsLost progressively in hepatocytes; absent in most immortalised lines
Glycogenesis and glycogenolysisGlucose storage and mobilisationRetained in some lines; often low and unmeasured

Important distinction. Expression of PEPCK and G6PC is necessary for gluconeogenesis and not sufficient for it. A line can transcribe both enzymes and produce no net glucose, because the substrate supply, the mitochondrial oxaloacetate export route and the redox balance are all required. Regulatory claims built on enzyme expression alone are the most common weakness in this literature.

The same applies to glycogen: content is a balance of synthesis and degradation, and it can be constant while both rates are high.

Part 1 — Demonstrating That Gluconeogenesis Is Active

Three designs, in increasing strength.

DesignWhat it showsRequirement
Glucose release into glucose-free mediumNet production of glucoseNo glucose in the medium; no serum glucose; a substrate (lactate, pyruvate, glycerol, amino acids) supplied
¹³C substrate to ¹³C glucoseCarbon from a non-glucose substrate entering glucoseTracer at a defined concentration; isotopologue analysis of glucose; correction for glycogen contribution
Both, with a pathway inhibitor or enzyme knockdownThat the release depends on the gluconeogenic routeA specific perturbation with a rescue

Readout note. Glucose release measured without removing glucose from the medium measures nothing. Serum contains glucose, phenol-red-free formulations vary, and glycogen breakdown can supply glucose in the absence of gluconeogenesis. The minimum design is glucose-free, serum-free (or dialysed) medium, a defined substrate, and a matched no-substrate control.

The third design is what makes the claim regulatory rather than descriptive. A knockdown of PC, PEPCK or G6PC that reduces glucose release, with a substrate-independent rescue, is a requirement claim; a change in their mRNA is not.

Part 2 — Model Choice for Gluconeogenic Work

ModelRetains gluconeogenesisPractical note
Primary human hepatocytesYes, for daysDedifferentiate rapidly; 3D or sandwich culture extends the window
Primary mouse hepatocytesYes, short windowSame limitation; isolation stress affects the first day
HepG2, Huh7Minimal to noneFrequently used and inappropriate for flux claims
iPSC-derived hepatocytesVariable, often lowRequires demonstration in each differentiation batch
Renal proximal tubule cellsYes, in some preparationsUnderused; also dedifferentiate

Caveat on hepatocyte dedifferentiation. The loss is not only transcriptional: mitochondrial function, transporter expression and medium composition all change. A gluconeogenesis experiment in hepatocytes beyond the first few days is usually measuring the culture system rather than the biology, unless the culture format has been validated for the route.

A practical approach that avoids most of this: perform the flux experiment within the validated window, and treat regulatory manipulations that require longer culture as a separate question with its own validation.

Part 3 — Glycogen: Content, Flux and the Distinction

MeasurementWhat it reportsLimitation
Glycogen content (acid hydrolysis + glucose assay)Standing amountCannot distinguish synthesis from degradation
Glycogen labelling from ¹³C-glucoseSynthesis over the labelling windowDepends on glucose uptake and on pool size
Labelling washout into unlabelled mediumDegradationRequires a pre-labelling step and a defined chase
Glycogen synthase or phosphorylase perturbationRequirement for the enzymesCompensation; growth effects
PAS stainingDistribution and abundanceNot quantitative without careful controls

Important distinction. A regulatory claim about glycogen is usually one of three: synthesis rate changed, degradation rate changed, or content changed. The third is compatible with either of the first two and with none of them changing.

The strongest design is a paired one: label incorporation (synthesis) plus washout (degradation) in the same model, with content measured at both ends. Where only content is feasible, the claim should be stated as a content claim.

Part 4 — Regulatory Claims and Their Evidence

ClaimMinimum evidenceWhat does not count
"Hormone or nutrient X increases gluconeogenesis"Glucose release from a defined substrate, with dose–response and an enzyme-level requirementPEPCK/G6PC mRNA
"X regulates glycogen synthesis"Label incorporation into glycogen, with a synthase perturbationGlycogen content
"X causes glycogen accumulation"Content plus labelling or degradation data to show which rate changedPAS staining alone
"The model is gluconeogenic"Glucose release with a substrate, or ¹³C incorporation into glucoseEnzyme expression; a hepatocyte name

The first row's dose–response requirement is not a formality: several gluconeogenic regulators act biphasically, and a single concentration can produce the opposite of the effect at a different dose.

Part 5 — Insulin, Glucagon and the Signalling Layer

The classical regulators act through signalling that changes both transcription and acute enzyme activity, and the two timescales are different experiments.

  • • Acute regulation (minutes): phosphorylation of glycogen synthase and phosphorylase; allosteric effects; substrate supply. Measured by enzyme activity ratios and by flux over short windows.
  • • Transcriptional regulation (hours): PEPCK, G6PC, glucokinase. Measured by mRNA and protein, and only interpretable as flux if a flux measurement accompanies it.

A study that treats a transcriptional change as evidence of a flux change has measured the slower arm and reported the faster one. The opposite error is also common: a 30-minute flux change attributed to transcription.

Part 6 — Model Requirements and Recurring Failures

RequirementWhy
Glucose-free, low-serum medium for release assaysOtherwise the measurement includes medium glucose
Substrate defined and matched control without itSeparates gluconeogenesis from glycogenolysis
Culture window validated for the routeDedifferentiation changes capacity
Glycogen measured alongside glucose releaseThe release may be glycogen-derived
Substrate concentration documentedFlux depends on precursor supply
Timecourse for the flux measurementAcute and transcriptional effects differ in timing

Recurring failures:

  • • Enzyme expression reported as gluconeogenic capacity in a line that cannot perform it.
  • • Glucose release measured in glucose-containing medium.
  • • Glycogen-derived glucose attributed to gluconeogenesis, because glycogen was not measured.
  • • Hepatoma lines used for gluconeogenesis claims without demonstration.
  • • Glycogen content reported as a flux.
  • • Single timepoint used to distinguish acute from transcriptional regulation.
  • • Insulin or glucagon dose not titrated, in a system where the response is biphasic.

Part 7 — Where This Article Connects

These two routes are the storage and synthesis arms of the pillar's glucose module, and they compete with glycolysis and the PPP for the same glucose-6-phosphate pool. The PPP article in this cluster covers the third branch; the glycogen assay article covers the measurement in more detail; and the tracing articles cover the isotope designs that make carbon attribution possible.

If you need gluconeogenic or glycogen flux demonstrated before it is regulated, we can scope the design with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Gluconeogenic and glycogenic capacity vary widely between species, cell types and culture formats, and decline with time in culture. The designs here describe how to demonstrate the route, not which model retains it.

Enzyme expression does not establish pathway activity, and glycogen content does not establish either synthesis or degradation rate.

Scientific interpretation and experimental design

  • • Demonstrate the route before regulating it. Expression is not activity.
  • • Remove glucose from the medium. Otherwise the release assay measures the medium.
  • • Measure glycogen when measuring glucose release. Otherwise the source is ambiguous.
  • • Content is not flux. Pair labelling with washout.
  • • Respect the culture window. Dedifferentiation is fast and not only transcriptional.
  • • Separate acute from transcriptional regulation by timing.

Selected references for further reading

  • • Adeva-Andany MM, et al. Liver glucose metabolism in humans. Bioscience Reports. 2016;36:e00416.
  • • Rui L. Energy metabolism in the liver. Comprehensive Physiology. 2014;4:177–197.
  • • Raja V, Natarajan S, Singh A. Glycogen metabolism and its role in growth and development. Journal of Biosciences. 2023;48:32.
  • • Sun RC, Denko NC. Quantitative analysis of glycogen metabolism in cultured cells. Methods in Enzymology. 2020;629:1–24.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: